▲ Peaking
Business
Newly approved pancreatic cancer drug shows promise in lung cancer
A newly approved pancreatic cancer drug has shown unexpected promise in treating lung cancer.
Lung Cancer
12 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Lung Cancer
This hub groups 12 separate news trends connected to Lung Cancer, spanning June 23, 2026 through September 3, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 70 article observations and 66 source signals, led by Health, Business coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Health
Lung cancer can stay silent for years: Who should get screened and why early detection matters
Medical experts and health outlets are spotlighting the vital role of early screening to combat the long-term silent progression of lung cancer.
◼ Archived
Business
🔮 fades ✓
AstraZeneca Ends Phase 3 Lung Cancer Drug Trial After Review
AstraZeneca has abruptly terminated its Phase 3 trial for the lung cancer drug volrustomig, halting development after an internal review.
◼ Archived
Business
Cullinan tees up J&J fight—and $100M payday—as Taiho-partnered drug hits phase 3 cancer goal
Cullinan and Taiho's lung cancer drug has passed a major clinical trial, setting up a potential challenge to Johnson & Johnson's market-leading treatment.
◼ Archived
Health
Non-Smoker, 38, Diagnosed With Stage 4 Lung Cancer After Doctors Dismissed Symptoms: ‘Nobody Was Worried’
Two non-smokers, an 11-year-old girl and a 38-year-old woman, have been diagnosed with stage 4 lung cancer.
◼ Archived
Health
🔮 fades ✓
Lung cancer is not only about smoking: Doctor explains the risks hiding in your air, home and daily routine
Medical discourse is shifting focus toward non-smoking related lung cancer, highlighting environmental and domestic hazards alongside technological screening tools.
◼ Archived
Health
🔮 fades ✓
Ask An Expert: What You Need to Know About Lung Cancer Testing
Lung cancer testing is evolving rapidly, with new advancements and barriers shaping patient care.
◼ Archived
Health
🔮 fades ✓
Vaping may be creating the next wave of lung cancer: Oncologists explain why new-age smoking habits are more dangerous than many people think
Oncologists are raising concerns that vaping may trigger a new wave of lung cancer, challenging the perception that e-cigarettes are a safer alternative.
◼ Archived
Health
🔮 fades ✗
Lung cancer in non-smoking women: "A women's health crisis"
Reports are highlighting a rise in lung cancer among women and individuals who have never smoked, labeling the trend a women's health crisis.
◼ Archived
Health
🔮 fades ✓
Non-smokers under 50 are getting lung cancer. What they eat raised a red flag
Research indicates an unexpected rise in lung cancer cases among non-smokers under 50, with new attention focused on dietary risks.
◼ Archived
Health
🔮 fades ✓
Rare transplant gives Stage 4 lung cancer patients a second chance at life
Recent study findings indicate lung transplants may improve survival outcomes for patients diagnosed with stage 4 lung cancer.
◼ Archived
Business
🔮 fades ✓
Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer
Pfizer's Phase 3 trial for the lung cancer drug Sigvotatug Vedotin failed to meet its primary endpoint for survival.